标题
GPR55: a new promising target for metabolism?
作者
关键词
-
出版物
JOURNAL OF MOLECULAR ENDOCRINOLOGY
Volume 58, Issue 3, Pages R191-R202
出版商
Bioscientifica
发表日期
2017-02-15
DOI
10.1530/jme-16-0253
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Advances Towards The Discovery of GPR55 Ligands
- (2016) Paula Morales et al. CURRENT MEDICINAL CHEMISTRY
- GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans
- (2016) Bo Liu et al. DIABETES OBESITY & METABOLISM
- Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice
- (2016) Aine M. McKillop et al. DIABETOLOGIA
- Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology
- (2016) Paula Morales et al. JOURNAL OF MEDICINAL CHEMISTRY
- The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease
- (2016) C. Hasenoehrl et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Selective GPR55 antagonism reduces chemoresistance in cancer cells
- (2016) Nagendra S. Singh et al. PHARMACOLOGICAL RESEARCH
- From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
- (2016) Alessia Ligresti et al. PHYSIOLOGICAL REVIEWS
- Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation
- (2016) Mikael Bjursell et al. PLoS One
- Central administration of GPR55 receptor agonist and antagonist modulates anxiety-related behaviors in rats
- (2015) Abbasali Rahimi et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity
- (2015) A Meadows et al. INTERNATIONAL JOURNAL OF OBESITY
- The GPR55 antagonist CID16020046 protects against intestinal inflammation
- (2015) A. Stančić et al. NEUROGASTROENTEROLOGY AND MOTILITY
- CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum
- (2014) E. Martínez-Pinilla et al. EXPERIMENTAL NEUROLOGY
- Regulation of GPR55 in rat white adipose tissue and serum LPI by nutritional status, gestation, gender and pituitary factors
- (2014) Monica Imbernon et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- (R,R′)-4′-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motility
- (2013) Rajib K. Paul et al. BIOCHEMICAL PHARMACOLOGY
- Identification of the GPR55 Antagonist Binding Site Using a Novel Set of High-Potency GPR55 Selective Ligands
- (2013) Evangelia Kotsikorou et al. BIOCHEMISTRY
- The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
- (2013) Cristoforo Silvestri et al. Cell Metabolism
- A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice
- (2013) Kun Li et al. NEUROPHARMACOLOGY
- GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination
- (2013) Chia-Shan Wu et al. PLoS One
- Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses
- (2013) S. Sylantyev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A potential role for GPR55 in gastrointestinal functions
- (2012) Rudolf Schicho et al. CURRENT OPINION IN PHARMACOLOGY
- A homology modeling study toward the understanding of three-dimensional structure and putative pharmacological profile of the G-protein coupled receptor GPR55
- (2012) Orgil Elbegdorj et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas
- (2012) E Pérez-Gómez et al. ONCOGENE
- Evidence for the Putative Cannabinoid Receptor (GPR55)-Mediated Inhibitory Effects on Intestinal Contractility in Mice
- (2012) Gracious R. Ross et al. PHARMACOLOGY
- GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils
- (2011) Nariman A B Balenga et al. CELL RESEARCH
- The L- -Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity
- (2011) J. M. Moreno-Navarrete et al. DIABETES
- The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats
- (2011) A. Díaz-Arteaga et al. DIABETES OBESITY & METABOLISM
- A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
- (2011) Silvana Y Romero-Zerbo et al. JOURNAL OF ENDOCRINOLOGY
- Pharmacology of GPR55 in Yeast and Identification of GSK494581A as a Mixed-Activity Glycine Transporter Subtype 1 Inhibitor and GPR55 Agonist
- (2011) A. J. Brown et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells
- (2011) Toshiki Chiba et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55
- (2011) Christopher M. Henstridge et al. MOLECULAR ENDOCRINOLOGY
- A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents
- (2011) X.-H. Lin et al. NEUROGASTROENTEROLOGY AND MOTILITY
- L-α-Lysophosphatidylinositol meets GPR55: a deadly relationship
- (2011) Ruth A. Ross TRENDS IN PHARMACOLOGICAL SCIENCES
- Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and ‘cannabinoid-like’ receptors in small arteries
- (2010) CJ Daly et al. BRITISH JOURNAL OF PHARMACOLOGY
- The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives
- (2010) Onder Tonyali et al. EXPERT OPINION ON PHARMACOTHERAPY
- The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment
- (2010) Rudolf Schicho et al. INFLAMMATORY BOWEL DISEASES
- Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors
- (2010) Bogna Ignatowska-Jankowska et al. NEUROSCIENCE LETTERS
- The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK
- (2010) C Andradas et al. ONCOGENE
- The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
- (2010) R Piñeiro et al. ONCOGENE
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Functional polymorphism in the GPR55 gene is associated with anorexia nervosa
- (2010) Hiroki Ishiguro et al. SYNAPSE
- Obesity and Cancer Risk: Recent Review and Evidence
- (2010) Karen Basen-Engquist et al. Current Oncology Reports
- Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3-L1 fibroblast cell line
- (2009) Martin T Gericke et al. BRITISH JOURNAL OF PHARMACOLOGY
- Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands
- (2009) Ankur Kapur et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo
- (2009) L. S. Whyte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The enigmatic pharmacology of GPR55
- (2009) Ruth A. Ross TRENDS IN PHARMACOLOGICAL SCIENCES
- The GPR55 ligand l-α-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation
- (2008) Christopher M. Henstridge et al. FASEB JOURNAL
- 2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55
- (2008) S. Oka et al. JOURNAL OF BIOCHEMISTRY
- Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression
- (2008) M. Waldeck-Weiermair et al. JOURNAL OF CELL SCIENCE
- Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
- (2008) Douglas Osei-Hyiaman et al. JOURNAL OF CLINICAL INVESTIGATION
- The Cannabinoid CB1 Receptor Antagonist Rimonabant Stimulates 2-Deoxyglucose Uptake in Skeletal Muscle Cells by Regulating the Expression of Phosphatidylinositol-3-kinase
- (2008) I. Esposito et al. MOLECULAR PHARMACOLOGY
- Targeting the endocannabinoid system: to enhance or reduce?
- (2008) Vincenzo Di Marzo NATURE REVIEWS DRUG DISCOVERY
- The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain
- (2008) Penny C. Staton et al. PAIN
- GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
- (2008) J. E. Lauckner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GPR55: a new member of the cannabinoid receptor clan?
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
- (2007) D G Johns et al. BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now